123I-labeled chitinase as specific radioligand for in vivo detection of fungal infections in mice

Journal of Nuclear Medicine

Volumn 45, Issue 7, 2004, Pages 1209-1216

  Siaens, Rien ^a,d   Eijsink, Vincent G H ^b   Dierckx, Rudi ^c   Slegers, Guido ^a  

^a GHENT UNIVERSITY   (Belgium)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d NONE   (Belgium)

Author keywords

123I chitinase; Aspergillus fumigatus; Bacteria; Candida albicans; Infection imaging

Indexed keywords

CHITINASE; IODINE 123; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; BINDING ASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INFLAMMATION; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SCINTIGRAPHY; SERRATIA MARCESCENS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY; ANIMAL; ANTIBODY SPECIFICITY; ASPERGILLOSIS; CANDIDIASIS; COMPARATIVE STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; MALE; METABOLIC CLEARANCE RATE; METABOLISM; MYOSITIS; NUDE MOUSE; SCINTISCANNING; STAPHYLOCOCCUS INFECTION; TISSUE DISTRIBUTION;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CHITINASE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; IODINE RADIOISOTOPES; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; MYCOSES; MYOSITIS; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TISSUE DISTRIBUTION;

EID: 4043102631     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Boerman O, Rennen H, Oyen WJ, Corstens FH. New concepts in infection/inflammation imaging. Q J Nucl Med. 2001;45:167-173.
2. de Winter F, Vogelaers D, Gemmel F, Siaens R, Slegers G, Dierckx R. The rising incidence of invasive fungal infections: is there a role for nuclear medicine? In: Hossri Nogueira Braga FJ, ed. Nuclear Medicine in Tropical Infectious Diseases. Boston, MA: Kluwer Academic; 2002:200-208.
3. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis. 2001;21:161-172.
4. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781-805.
5. Frazier DD, Cambell DR, Garvey TA, Wiesel SA, Bolhman HH, Eismont FJ. Fungal infections of the spine. J Bone Joint Surg Am. 2001;83:560-565.
6. Lupetti A, Welling MM, Mazz U, Nibbering PH, Pauwels EKJ. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med. 2002;29:674-679.
7. Stynen D, Sarfati J, Goris A, et al. Rat monoclonal antibodies against Aspergillus gallactomannan. Infect Immun. 1992;60:2237-2245.
8. 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neurtopenic rats. Nucl Med Biol. 2002;29:177-184.
9. Rubin RH, Fischman AJ. Radionuclide imaging of infection in the immunocompromised host. Clin Infect Dis. 1996;22:414-423.
10. Wills EA, Redinbo MR, Perfect JR, Poeta MD. New potential targets for antifungal development. Expert Opin Ther Targets. 2002;4:265-296.
11. Koga D, Mitsutomi M, Kono M, Matsumiya M. Biochemistry of chitinases. In: Jollès P, Muzzarelli RA, eds. Chitin and Chitinases. Berlin, Germany: Birkhäuser Verlag; 1999:111-123.
12. Renkma GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM. Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem. 1995;270:2198-2202.
13. Tjoelker LW, Gosting L, Frey S, et al. Structural and functional definition of the human chitinase chitin-binding domain. J Biol Chem. 2000;275:514-520.
14. Robertus JD, Monzingo AF. The structure and action of chitinases. In: Jollès P, Muzzarelli RA, eds. Chitin and Chitinases. Berlin, Germany: Birkhäuser Verlag; 1999:125-135.
15. van Aalten DMF, Synstad B, Bruberg MB, et al. Structure of a two-domain chitotriosidase from Serratia marcescens at 1.9-Å resolution. Proc Natl Acad Sci USA. 2000;97:5842-5847.
16. Synstad B, Gåseidnes S, Vriend G, Nielsen J-E, Eijsink VGH. On the contribution of conserved acidic residues to catalytic activity of chitinase B from Serratia marcescens. In: Peter MG, Muzzarelli RAA, Domard A, eds. Advances in Chitin Science. Vol. 4. Ås, Norway: University of Norway; 2000:524-529.
17. Watanabe T, Ariga Y, Sato U, et al. Aromatic residues within the substrate-binding cleft of Bacillus circulans chitinase A1 are essential for crystalline chitin hydrolysis. Biochem J. 2003;376:237-244.
18. Watanabe T, Ishibashi A, Ariga Y, et al. Trp122 and Trp134 on the surface of the catalytic domain are essential for crystalline chitin hydrolysis by Bacillus circulans chitinase A1. FEBS Lett. 2001;494:74-88.
19. Uchiyama T, Katouno F, Nikaidou N, Nonaka T, Sugiyama J, Watanabe T. Roles of the exposed aromatic residues in crystalline chitin hydrolysis by chitinase A from Serratia marcescens 2170. J Biol Chem. 2001;276:41343-41349.
20. Brurberg MB, Nes IF, Eijsink VGH. Comparative studies of chitinases A and B from Serratia marcescens. Microbiology. 1996;142:1581-1589.
21. Garg PK, Alston KL, Welsh PC, Zalutsky PR. Enhanced binding and inertness to dehalogenation of melantropic peptides labelled using N-succinimidyl 3-iodobenzoate. Bioconjug Chem. 1996;7:233-239.
22. 131I-labeled biphosphonates with high in vivo stability and bone accumulation. J Nucl Med. 1999;40:1197-1203.
23. Sumpio BE, Maack T. Kinetics, competition and selectivity of tubular absorption of proteins. Am J Physiol. 1982;243:F379-F392.
24. Behr TM, Goldenberg DM, Becker W. Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations. Eur J Nucl Med. 1998;25:201-212.
25. van Aalten DM, Komander D, Synstad B, Gaseidne S, Peter MG, Eijsink VGH. Structural insights into the catalytic mechanism of a family 18 exo-chitinase. Proc Natl Acad Sci USA. 2001;98:8979-8984.
26. 99mTc-Labeled antimicrobial peptides for detection of bacterial and Candida albicans infections [reply to letter]. J Nucl Med. 2002;43:1126-1127.